Investigation of Ornithine Decarboxylase Activity and Two-Dimensional Electrophoretic Protein Profile Following Exposure of T24 Bladder Carcinoma Cells to Tumor Promoter and Carcinogen

Toxicology Methods

Volumn 7, Issue 1, 1997, Pages 27-41

  Kanitz, M Helen ^a   Li, E I ^a   Schulte, P A ^a   Anderson, N L ^b   Rothman, N ^c   Savage Jr , R E ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b Large Scale Biology Corporation   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

2D PAGE; Biomarker; Bladder carcinogenesis; Occupational exposure; ODC

Indexed keywords

EID: 0013459332     PISSN: 10517235     EISSN: None     Source Type: Journal    
DOI: 10.1080/105172397243295     Document Type: Article

References (33)

1. American Cancer Society. Cancer Facts and Figures - 1995. Atlanta, GA, 95-375M-No5008.95; 1995.
2. Silverberg E, Boring C, Squires TS. Cancer statistics 1990. CA. 1990;40:9-26.
3. Gordon GB, Helzlouer KJ, Comstock GW. Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer. Cancer Res. 1991;51:1366-1369.
4. Rubben H, Lutzeyer W, Wallace DMA. The epidemiology and aetiology of bladder cancer. In: Zingg EJ, Wallace DM, eds. Bladder Cancer, Clinical Practice in Urology Series. New York: Springer; 1985: 1-27.
5. Sporn MB. Carcinogenesis and cancer: different perspectives on the same disease. Cancer Res. 1991;51:6215-6218.
6. Perera FP. Molecular cancer epidemiology: a new tool in cancer prevention. J Natl Cancer Inst. 1987;78:887-898.
7. Singh J, Kelloff G, Reddy BS. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis. Cancer Epidem. Biomarkers Prevention. 1992;1:405-411.
8. Hsieh JT, Verma AK. Involvement of protein kinase C in the transcriptional regulation of ornithine decarboxylase gene expression by 12-o-tetradecanoylphorbol-13-acetate in T24 human bladder carcinoma cells. Arch Biochem Biophys. 1988;262:326-336.
9. Russell DH. Ornithine decarboxylase: A key regulatory enzyme in normal and neoplastic growth. Drug Metabolic Rev. 1985;16:1-88.
10. Anderson G, Heby O. Polyamine and nucleic acid concentrations in Ehrlich ascites carcinoma cells and liver of tumor bearing mice at various stages of tumor growth. J Natl Cancer Inst. 1972;48:165-172.
11. O'Brian TG. The induction of ornithine decarboxylase as an early possibly obligatory event in mouse skin carcinogenesis. Cancer Res. 1976;36:2644-2653.
12. Luk GD, Hamilton SR, Yang P, et al. Kinetic changes in mucosal ornithine decarboxylase activity during azoxymethane-induced colonic carcinogenesis in the rat. Cancer Res. 1986;46:4449-4452.
13. Kingsworth AN, King WWK, Diekema KA, McCann PP, Ross JS, Malt RA. Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: reduced incidence of dimethylhydrazine induced colon tumor in mice. Cancer Res. 1983;43:2545-2549.
14. Gilmour SK, Verma AK, Madara T, O'Brien TG. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis. Cancer Res. 1987;47: 1221-1225.
15. Claverie N, Mamont PS. Comparative antitumor properties in rodents of irreversible inhibitors of l-ornithine decarboxylase, used as such or as prodrugs. Cancer Res. 1989;49:4466-4471.
16. Homma Y, Kakizoe T, Samma S, Oyasu R. Inhibition of n-butyl-n-(4-hydroxybutyl) nitrosamine-induced rat urinary bladder carcinogenesis by a-difluoromethylornithine. Cancer Res. 1987;47:6176-6179.
17. Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of bladder cancer. In: Skinner D, Lieskovsky G, eds. Diagnosis and Management of Genitourinary Cancer. Philadelphia, PA: Saunders; 1988:23-31.
18. Case RAM, Hosker ME, McDonald DB, Pearson JT. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry, 1: the role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. Br J Ind Med. 1954;11:75-104.
19. Melick WF, Naryka JJ, Kelly RE. Bladder cancer due to exposure to para-aminobiphenyl: a 17-year followup. J Urol. 1971;106:220-226.
20. Haugen DA, Peak MJ, Suhbler KM, Stamoudis VC. Isolation of mutagenic amines from a coal conversion oil by cation exchange chromatography. Anal Chem. 1982;54:32-37.
21. Talaska G, Al-Juburi AZSS, Kadlubar FF. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl) 4-aminobiphenyl as a major adduct. Proc Natl Acad Sci. 1991;88:5350-5354.
22. Kuller LH, Garfinkel L, Correa P, et al. Contribution of passive smoking to respiratory cancer. Environ Health Perspect. 1986;70:57-69.
23. Seidel ER. Hormonal regulation of postprandial induction of gastrointestinal ornithine decarboxylase activity. Am J Physiol. 1986;251:460-466.
24. Bachrach U. The induction of ornithine decarboxylase in normal and neoplastic cells. In: Gaugus JM, ed. Polyamines in Biomedical Research. New York: Wiley; 1980:81-107.
25. Nicolson GL. Gene expression, cellular diversification and tumor progression to the metastatic phenotype. BioEssays. 1991;13:337-342.
26. Bubenick J, Baresova M, Vicklicky V, Jakoubkova J, Sainerova H, Donner J. Established cell line of urinary bladder carcinoma (T24) containing tumour specific antigen. Int J Cancer. 1973;11:765-773.
27. Anderson NL. Two-Dimensional Electrophoresis: Operation of the ISO-DALT System. Washington, DC: Large Scale Biology; 1988.
28. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 1988;44:4924-4928.
29. Nishioka K, Grossie VB, Chang TH, Ajani JA, Ota DM. Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa. J Surg Oncol. 1991;47:117-120.
30. Moorhead RJ, Hoper M, McKelvey STD. Assessment of ODC activity in rectal mucosa as a marker for colorectal adenomas and carcinomas. Br J Surg. 1987;74:364-365.
31. Love RR, Surawicz TS, Morrisey JF, Verma AK. Levels of colorectal ornithine decarboxylase activity in patients with colon cancer, a family history of nonpolyposis hereditary colonic cancer, a family history of nonpolyposis hereditary colonic cancer and adenomas. Cancer Epidemiol Biomarkers Prev. 1992;1:195-198.
32. Miller MJ, Schwartz DM, Thorgeirsson SS. Inter-and intraclonal variability of polypeptides synthesized in a rat hepatoma cell line: quantitative two-dimensional gel analysis. J Biol Chem. 1988;263: 11227-11236.
33. Hemstreet GP, Rao JY, Hurst RE, et al. Intermediate endpoint biomarkers for chemoprevention. J Cell Biochem Suppl. 1992;161:93-110.